| Record Information |
|---|
| Version | 2.0 |
|---|
| Created at | 2022-04-28 11:00:50 UTC |
|---|
| Updated at | 2022-04-28 11:00:50 UTC |
|---|
| NP-MRD ID | NP0066778 |
|---|
| Secondary Accession Numbers | None |
|---|
| Natural Product Identification |
|---|
| Common Name | (-)-N-Demethylgalanthamine |
|---|
| Description | Norgalanthamine belongs to the class of organic compounds known as galanthamine-type amaryllidaceae alkaloids. These are amaryllidaceae alkaloids with a structure characterized a tetracyclic skeleton with two ortho aromatic protons in ring A. Norgalanthamine is a primary metabolite. Primary metabolites are metabolically or physiologically essential metabolites. They are directly involved in an organism’s growth, development or reproduction. (-)-N-Demethylgalanthamine is found in Crinum asiaticum L. , Crinum jagus , Galanthus elewesii, Galanthus elwesii, Hymenocallis rotata, Leucojum vernum, Lycoris aurea, Lycoris squamigera, Narcissus leonensis, Narcissus pseudonarcissus, Narcissus pseudonarcissus subsp.pseudonarcissus, Pancratium maritium and Pancratium sickenbergeri. (-)-N-Demethylgalanthamine was first documented in 2010 (PMID: 19822478). Based on a literature review a small amount of articles have been published on Norgalanthamine (PMID: 34915776) (PMID: 30606985) (PMID: 27073702) (PMID: 26129719). |
|---|
| Structure | COC1=C2O[C@H]3C[C@@H](O)C=C[C@]33CCNCC(C=C1)=C23 InChI=1S/C16H19NO3/c1-19-12-3-2-10-9-17-7-6-16-5-4-11(18)8-13(16)20-15(12)14(10)16/h2-5,11,13,17-18H,6-9H2,1H3/t11-,13-,16-/m0/s1 |
|---|
| Synonyms | | Value | Source |
|---|
| N-Demethylgalanthamine | Kegg |
|
|---|
| Chemical Formula | C16H19NO3 |
|---|
| Average Mass | 273.3320 Da |
|---|
| Monoisotopic Mass | 273.13649 Da |
|---|
| IUPAC Name | (1S,12S,14R)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol |
|---|
| Traditional Name | (1S,12S,14R)-9-methoxy-11-oxa-4-azatetracyclo[8.6.1.0^{1,12}.0^{6,17}]heptadeca-6(17),7,9,15-tetraen-14-ol |
|---|
| CAS Registry Number | Not Available |
|---|
| SMILES | COC1=C2O[C@H]3C[C@@H](O)C=C[C@]33CCNCC(C=C1)=C23 |
|---|
| InChI Identifier | InChI=1S/C16H19NO3/c1-19-12-3-2-10-9-17-7-6-16-5-4-11(18)8-13(16)20-15(12)14(10)16/h2-5,11,13,17-18H,6-9H2,1H3/t11-,13-,16-/m0/s1 |
|---|
| InChI Key | AIXQQSTVOSFSMO-RBOXIYTFSA-N |
|---|
| Experimental Spectra |
|---|
|
| Not Available | | Predicted Spectra |
|---|
|
| | Spectrum Type | Description | Depositor ID | Depositor Organization | Depositor | Deposition Date | View |
|---|
| 1D NMR | 13C NMR Spectrum (1D, 25 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 100 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 252 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 1000 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 50 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 200 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 75 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 300 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 101 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 400 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 126 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 500 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 151 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 600 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 176 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 700 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 201 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 800 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 13C NMR Spectrum (1D, 226 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum | | 1D NMR | 1H NMR Spectrum (1D, 900 MHz, D2O, predicted) | Wishart Lab | Wishart Lab | David Wishart | 2021-06-20 | View Spectrum |
| | Chemical Shift Submissions |
|---|
|
| Not Available | | Species |
|---|
| Species of Origin | |
|---|
| Chemical Taxonomy |
|---|
| Description | Belongs to the class of organic compounds known as galanthamine-type amaryllidaceae alkaloids. These are amaryllidaceae alkaloids with a structure characterized a tetracyclic skeleton with two ortho aromatic protons in ring A. |
|---|
| Kingdom | Organic compounds |
|---|
| Super Class | Alkaloids and derivatives |
|---|
| Class | Amaryllidaceae alkaloids |
|---|
| Sub Class | Galanthamine-type amaryllidaceae alkaloids |
|---|
| Direct Parent | Galanthamine-type amaryllidaceae alkaloids |
|---|
| Alternative Parents | |
|---|
| Substituents | - Galanthamine-type amaryllidaceae alkaloid
- Benzazepine
- Coumaran
- Anisole
- Alkyl aryl ether
- Azepine
- Aralkylamine
- Benzenoid
- Secondary alcohol
- Secondary aliphatic amine
- Ether
- Oxacycle
- Secondary amine
- Azacycle
- Organoheterocyclic compound
- Organic nitrogen compound
- Alcohol
- Hydrocarbon derivative
- Organonitrogen compound
- Organooxygen compound
- Amine
- Organic oxygen compound
- Organopnictogen compound
- Aromatic heteropolycyclic compound
|
|---|
| Molecular Framework | Aromatic heteropolycyclic compounds |
|---|
| External Descriptors | |
|---|
| Physical Properties |
|---|
| State | Not Available |
|---|
| Experimental Properties | | Property | Value | Reference |
|---|
| Melting Point | Not Available | Not Available | | Boiling Point | Not Available | Not Available | | Water Solubility | Not Available | Not Available | | LogP | Not Available | Not Available |
|
|---|
| Predicted Properties | |
|---|
| General References | - Yang N, Ko M, Ahn M, Shin T: Hepatoprotective effects of norgalanthamine on carbon tetrachloride induced-hepatotoxicity in mice. Drug Chem Toxicol. 2023 Jan;46(1):144-154. doi: 10.1080/01480545.2021.2015241. Epub 2021 Dec 16. [PubMed:34915776 ]
- Yoon HS, Kang JI, Kim SM, Ko A, Koh YS, Hyun JW, Yoon SP, Ahn MJ, Kim YH, Kang JH, Yoo ES, Kang HK: Norgalanthamine Stimulates Proliferation of Dermal Papilla Cells via Anagen-Activating Signaling Pathways. Biol Pharm Bull. 2019;42(1):139-143. doi: 10.1248/bpb.b18-00226. [PubMed:30606985 ]
- Imbernon-Moya A, Podlipnik S, Burgos F, Vargas-Laguna E, Aguilar-Martinez A, Fernandez-Cogolludo E, Gallego-Valdes MA: Acquired Localized Hypertrichosis Induced by Rivastigmine. Case Rep Dermatol Med. 2016;2016:7296572. doi: 10.1155/2016/7296572. Epub 2016 Mar 17. [PubMed:27073702 ]
- Vezenkov LT, Ilieva L, Danalev DL, Bakalova A, Vassilev DN, Danchev N, Nikolova I: Synthesis of New Peptide Derivatives of Galanthamine Designed for Prevention and Treatment of Alzheimer's Disease. Protein Pept Lett. 2015;22(10):913-22. doi: 10.2174/0929866522666150701111642. [PubMed:26129719 ]
- Kim SC, Kang JI, Kim MK, Hyun JH, Boo HJ, Park DB, Lee YJ, Yoo ES, Kim YH, Kim YH, Kang HK: Promotion effect of norgalanthamine, a component of Crinum asiaticum, on hair growth. Eur J Dermatol. 2010 Jan-Feb;20(1):42-8. doi: 10.1684/ejd.2010.0807. Epub 2009 Oct 12. [PubMed:19822478 ]
|
|---|